These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3262915)

  • 1. Effect of platelet-activating factor and its receptor antagonist, SRI 63-675, on gastric bleeding in rats.
    Berstad A; Almodovar K; Weatherstone RG; Hirschowitz BI
    Scand J Gastroenterol; 1988 Aug; 23(6):738-42. PubMed ID: 3262915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric bleeding and increased gastric vascular permeability induced by platelet activating factor (PAF): effect of drugs that affect arachidonate metabolism.
    Hatakeyama K; Yano S; Watanabe K
    Jpn J Pharmacol; 1991 Jul; 56(3):271-7. PubMed ID: 1910120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tranexamic acid on gastric bleeding in rats.
    Berstad A; Almodovar K; Berstad K; Anderson W; Hirschowitz BI
    Scand J Gastroenterol; 1988 May; 23(4):402-6. PubMed ID: 3260041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat.
    Thomas TK; Chesonis RS; Schmolze D; Symington J; Harbison ML; Walser A; Will PC
    Agents Actions; 1993; 39 Spec No():C195-7. PubMed ID: 8273566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants.
    Wallace JL; Whittle BJ
    Prostaglandins; 1986 May; 31(5):989-98. PubMed ID: 3726156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat.
    Esplugues JV; Whittle BJ
    Br J Pharmacol; 1988 Jan; 93(1):222-8. PubMed ID: 3349230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activating factor induced gastric damage in rats: participation of increased gastric vascular permeability.
    Hatakeyama K; Yano S; Watanabe K
    Scand J Gastroenterol Suppl; 1989; 162():71-4. PubMed ID: 2595312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa.
    Whittle BJ; Morishita T; Ohya Y; Leung FW; Guth PH
    Am J Physiol; 1986 Dec; 251(6 Pt 1):G772-8. PubMed ID: 3789144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of stimulation and inhibition of acid secretion on gastric damage induced by platelet-activating factor.
    Piqué JM; Pérez Ayuso RM; Bilbao J; Terés J
    Dig Dis Sci; 1991 Dec; 36(12):1715-20. PubMed ID: 1748040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric mucosal damage induced in rats by intravenous administration of platelet-activating factor.
    Binnaka T; Yamaguchi T; Hirohara J; Hiramatsu A; Mizuno T; Sameshima Y
    Scand J Gastroenterol Suppl; 1989; 162():67-70. PubMed ID: 2595311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.
    Filep JG; Hermán F; Földes-Filep E; Schneider F; Braquet P
    Br J Pharmacol; 1992 Apr; 105(4):912-8. PubMed ID: 1324056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of neutrophils in gastric damage induced by platelet activating factor.
    Etienne A; Thonier F; Hecquet F; Braquet P
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):422-5. PubMed ID: 3244384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of leukotrienes and platelet activating factor in acute gastric mucosal lesions in rats.
    Konturek SJ; Brzozowski T; Drozdowicz D; Garlicki J; Beck G
    Eur J Pharmacol; 1989 May; 164(2):285-92. PubMed ID: 2759176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat.
    Filep J; Hermán F; Braquet P
    Lipids; 1991 Dec; 26(12):1356-8. PubMed ID: 1819733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new model to assess the haemorrhagic potential of various heparin preparations.
    Berstad A; Bang CJ; Talstad I
    Acta Chir Scand Suppl; 1990; 556():62-7. PubMed ID: 1963019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central regulation of gastric acid secretion by platelet-activating factor in anesthesized rats.
    Cucala M; Wallace JL; Salas A; Guarner F; Rodriguez R; Malagelada JR
    Prostaglandins; 1989 Feb; 37(2):275-85. PubMed ID: 2499013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a platelet-activating factor antagonist, CV-6209, on gastric mucosal lesions induced by ischemia-reperfusion.
    Yoshikawa T; Takahashi S; Naito Y; Ueda S; Tanigawa T; Yoshida N; Kondo M
    Lipids; 1992 Dec; 27(12):1058-60. PubMed ID: 1487954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal damage induced by platelet-activating factor. Inhibition by the corticoid, dexamethasone.
    Wallace JL; Whittle BJ
    Dig Dis Sci; 1988 Feb; 33(2):225-32. PubMed ID: 3338370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of the PAF-antagonist BN 52021 on several models of gastro-intestinal mucosal damage in rats.
    Etienne A; Thonier F; Braquet P
    Int J Tissue React; 1989; 11(2):59-64. PubMed ID: 2693389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.